The impact of interferon-alpha treatment on clinical and immunovirological aspects of HTLV-1-associated myelopathy in northeast of Iran
Journal of Neuroimmunology, 06/26/2012
Rafatpanah H et al. – Flow cytometry showed no significant changes in CD4, CD8, CD4CD25 and CD16CD56 counts with interferon–alpha (IFN–α). The positive impact of IFN–α was observed during the treatment period with significant effects on some clinical aspects of human T–lymphotropic virus type 1 (HTLV–1)–associated myelopathy/tropical spastic paraparesis (HAM/TSP).